Illinois is currently home to 2661 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Chicago, Peoria, Springfield and Urbana. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
BUILT Family Lifestyle Program for Children With ADHD
NCT05464056
Recruiting
The investigators have developed BUILT in hopes of empowering families to adopt and sustain healthy food, sleep, and exercise routines that optimize child focus, attention, and behavior. Over 8-weeks, the BUILT program will explore what science says about the effects of sleep, nutrition, and exercise on brain development and behavior; investigate the food, sleep, and exercise routines of the world's best athletes and intellectuals; and experiment with home routines to find those that best fits w... Read More
Gender:
All
Ages:
Between 6 years and 12 years
Trial Updated:
07/14/2022
Locations: Chicago Park District, Chicago, Illinois
Conditions: Attention Deficit Hyperactivity Disorder
Register for Updates
Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)
NCT04775004
Recruiting
There are no current or past RCT comparing biologic augments for meniscal repair. There is good data supporting both the use of BMVP of the intercondylar notch and intra-articular PRP injections for augmentation of meniscal repair. However, the effectiveness of these augmentation methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this particular patient population. Additionally, resources availa... Read More
Gender:
All
Ages:
16 years and above
Trial Updated:
07/11/2022
Locations: University of Chicago Medicine, Chicago, Illinois
Conditions: Meniscal Tear
Register for Updates
The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device
NCT05445115
Recruiting
Study to evaluate the use of a medical device in relieving collision dyspareunia
Gender:
Female
Ages:
18 years and above
Trial Updated:
06/30/2022
Locations: Vero Clinics, Decatur, Illinois
Conditions: Dyspareunia
Register for Updates
PATH 2 Purpose: Primary Care and Community-Based Prevention of Mental Disorders in Adolescents
NCT04290754
Recruiting
PATH (Promoting AdolescenT Health) 2 Purpose is a two-arm comparative effectiveness research trial to that will evaluate the ability of the interventions, Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT) and Teens Achieving Mastery over Stress (TEAMS), to intervene early to prevent depressive illness and potentially other common mental health disorders. Using cluster randomization, 564 participants eligible for the study will be offered one of two diff... Read More
Gender:
All
Ages:
Between 13 years and 19 years
Trial Updated:
06/28/2022
Locations: UI Health, Chicago, Illinois
Conditions: Depression
Register for Updates
Repetitive Acute Intermittent Hypoxia for Spinal Cord Repair
NCT03433599
Recruiting
Our goal is to enhance repeated exposure to acute intermittent hypoxia (rAIH)/training-induced aftereffects on upper and lower limb function recovery in humans with chronic spinal cord injury (SCI).
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
06/28/2022
Locations: Shirley Ryan AbilityLab, Chicago, Illinois
Conditions: Spinal Cord Injuries
Register for Updates
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
NCT03394365
Recruiting
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab and rituximab plus chemotherapy or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Gender:
All
Ages:
All
Trial Updated:
06/23/2022
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago (Adults and Pediatrics), Chicago, Illinois
Conditions: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications
Register for Updates
Spasticity After Spinal Cord Injury
NCT04393922
Recruiting
Very often, people who have a SCI have difficulty doing things with their arms or hands as a result of muscle stiffness , or spasticity. Spastacity can cause problems performing even the simplest of everyday tasks. This research will help us understand how the body recovers and changes neurologically after SCI.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
06/20/2022
Locations: Shirley Ryan AbilityLab, Chicago, Illinois
Conditions: Spinal Cord Injuries
Register for Updates
Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study
NCT04671498
Recruiting
This study investigates if a new type of test called Droplet-BC screening test can classify breast cancer patients from non-cancer volunteers by circulating small-noncoding RNA in the blood with a statistical validity. This study also investigates if this test can classify the subgroup of breast cancer patients with a variety of conditions. Information from this study may provide a new method of breast cancer screening/diagnosis
Gender:
All
Ages:
18 years and above
Trial Updated:
06/15/2022
Locations: Northwestern University Feinberg School of Medicine, Chicago, Illinois
Conditions: Breast Carcinoma
Register for Updates
Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants
NCT03540121
Recruiting
This study aims to test the effectiveness of an electronic-based video intervention and behavioral contract on improving medication adherence among kidney transplant recipients.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/26/2022
Locations: University of Illinois Health Sciences System, Chicago, Illinois
Conditions: Kidney Transplantation, Medication Adherence
Register for Updates
Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients
NCT05264545
Recruiting
A 510k approved dental device for subjects requiring single or multiple tooth replacement with implants where immediate restoration/loading is preferred.
Gender:
All
Ages:
25 years and above
Trial Updated:
05/25/2022
Locations: Periodontal Medicine Surgical Specialists, LLC, Oakbrook Terrace, Illinois
Conditions: Partially Edentulous Maxilla or Mandible
Register for Updates
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
NCT02847559
Recruiting
The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field therapy has on meningiomas. Bevacizumab is considered investigational because the US Food and Drug Administration (FDA) has not approved its use for the treatment of meningiomas. The study drug is a medication that blocks the growth of new blood vessels. It is thought that the study drug may interfere with the growth of new blood vessels and th... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/25/2022
Locations: Northwestern University, Chicago, Illinois
Conditions: Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma
Register for Updates
Utilization of a Videoscope in Periodontal Regeneration
NCT05275192
Recruiting
Clinical and preclinical studies confirm that regeneration of supporting tissues of teeth lost due to periodontal disease can be achieved using the principles of minimally invasive surgery (MIS). Although this therapeutic approach is well established in clinical settings and can rescue teeth with poor or questionable prognosis, MIS approaches often suffer from lack of predictability due to poor intraoral visibility of the bony lesion and inability to confirm thorough removal of etiological facto... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
05/24/2022
Locations: University of Illinois, Chicago, College of Dentistry, Periodontics, Chicago, Illinois
Conditions: Chronic Periodontitis
Register for Updates